Webcast ImageWebcast
Q4 2014 Geron Earnings Conference Call (Replay)
03/03/15 at 4:30 p.m. ET
Q4 2014 Geron Earnings Conference Call
Tuesday, March 3, 2015 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Recent NewsMore >>
DateTitle 
03/03/15Geron Corporation Reports Fourth Quarter and Annual 2014 Financial Results and Recent EventsPrinter Friendly Version
02/26/15Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2014 Financial Results and Recent EventsPrinter Friendly Version
02/02/15Geron to Present at the 17th Annual BIO CEO & Investor ConferencePrinter Friendly Version
Upcoming EventsMore >>
To be announced.
Stock Information
GERN (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$2.96
Change (%) Stock is Down 0.06 (1.99%)
Volume2,206,615
Data as of 03/03/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
  
Contact Information

Kevin Eng, Ph.D.
Tel: 650-473-7765
E-mail: investor@geron.com or media@geron.com



RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | Financial Tear Sheet Financial Tear Sheet
Close
Form content here please :)